Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F13A1 | P00488 | 2/20 | 0.64 |
| ▸ | TGM2 | P21980 | 2/20 | 0.64 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.62 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.62 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.62 |
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.59 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.55 |
| ▸ | CTSB | P07858 | 2/20 | 0.55 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | TACR2 | P21452 | 3/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29713766 | 0.89 | DPP3 (0.63) | F13A1TGM2NTSR2NTSR1SORT1 | |
| SCHEMBL32681272 | 0.89 | DPP3 (0.62) | F13A1TGM2NTSR2NTSR1SORT1 | |
| SCHEMBL30439203 | 0.88 | F13A1 (0.63) | F13A1TGM2NTSR2NTSR1SORT1 | |
| SCHEMBL31507728 | 0.88 | NTSR2 (0.68) | NTSR2NTSR1SORT1DPP3CAPN1 | |
| SCHEMBL15800626 | 0.87 | TGM2 (0.75) | F13A1TGM2NTSR2NTSR1SORT1 | |
| SCHEMBL30288104 | 0.86 | DPP3 (0.71) | NTSR2NTSR1SORT1DPP3CAPN1 | |
| SCHEMBL6041189 | 0.86 | CXCR4 (0.61) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL30007955 | 0.86 | NTSR2 (0.65) | NTSR2NTSR1SORT1DPP3KISS1R | |
| SCHEMBL6041194 | 0.86 | CXCR4 (0.61) | NTSR2NTSR1SORT1CAPN1CTSB | |
| SCHEMBL32681280 | 0.86 | DPP3 (0.59) | F13A1TGM2NTSR2NTSR1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11472838-B2 | Inhibitors of blood coagulation factor XIII | ZEDIRA GMBH (DE) | 2022-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11472838-B2 | Inhibitors of blood coagulation factor XIII | TFPI, F11, F13B | F13A1 8/4885TGM2 383/4885NTSR2 2952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.